#cabometyx
Latest news and interesting information about cabometyx.
Cabometyx Cuts Neuroendocrine Tumor Risk
Exelixis announces Cabometyx reduces neuroendocrine tumor progression risk by 74% in CABINET trial. New data presented at ASCO.
...
Latest news and interesting information about cabometyx.